WallStreetZenWallStreetZen

NASDAQ: TVTX
Travere Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for TVTX

Based on 10 analysts offering 12 month price targets for Travere Therapeutics Inc.
Min Forecast
$8.00-4.99%
Avg Forecast
$20.00+137.53%
Max Forecast
$35.00+315.68%

Should I buy or sell TVTX stock?

Based on 10 analysts offering ratings for Travere Therapeutics Inc.
Strong Buy
Strong Buy
5 analysts 50%
Buy
4 analysts 40%
Hold
1 analysts 10%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TVTX stock forecasts and price targets.

TVTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Wedbush
Bottom 4%
4
BuyReiterates$12.00+42.52%2023-09-29
Barclays
Top 22%
79
Strong BuyMaintains$12.00+42.52%2023-09-22
Bank of America
Top 11%
90
Strong BuyMaintains$27.00+220.67%2023-09-22
Guggenheim
Top 4%
97
Strong BuyMaintains$18.00+113.78%2023-09-22
Evercore ISI Group
Top 9%
92
BuyMaintains$14.00+66.27%2023-09-22
HC Wainwright & Co.
Bottom 2%
2
BuyMaintains$18.00+113.78%2023-09-22
Wells Fargo
Top 11%
90
HoldDowngrades$8.00-4.99%2023-09-22
Piper Sandler
HoldMaintains$19.00+125.65%2023-08-18
JP Morgan
Bottom 2%
2
Strong BuyInitiates Coverage On$26.00+208.79%2023-07-21
Canaccord Genuity
Bottom 19%
19
Strong BuyMaintains$35.00+315.68%2023-07-18

1 of 2

Forecast return on equity

Is TVTX forecast to generate an efficient return?
Company
N/A
Industry
0.66%
Market
28.71%

Forecast return on assets

Is TVTX forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.05%

TVTX revenue growth forecast

How is TVTX forecast to perform vs Biotechnology companies and vs the US market?
Company
34.39%
Industry
34.31%
Market
8.24%
TVTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TVTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TVTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TVTX$8.42$20.00+137.53%Strong Buy
VRDN$14.60$42.56+191.48%Strong Buy
KURA$8.60$25.94+201.60%Strong Buy
GNLX$24.75$34.33+38.72%Buy
PRTC$21.55N/AN/A

Travere Therapeutics Stock Forecast FAQ

Is Travere Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NASDAQ: TVTX) stock is to Strong Buy TVTX stock.

Out of 10 analysts, 5 (50%) are recommending TVTX as a Strong Buy, 4 (40%) are recommending TVTX as a Buy, 1 (10%) are recommending TVTX as a Hold, 0 (0%) are recommending TVTX as a Sell, and 0 (0%) are recommending TVTX as a Strong Sell.

If you're new to stock investing, here's how to buy Travere Therapeutics stock.

What is TVTX's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: TVTX) forecast ROE is N/A, which is considered weak.

What is TVTX's Price Target?

According to 10 Wall Street analysts that have issued a 1 year TVTX price target, the average TVTX price target is $20.00, with the highest TVTX stock price forecast at $35.00 and the lowest TVTX stock price forecast at $8.00.

On average, Wall Street analysts predict that Travere Therapeutics's share price could reach $20.00 by Sep 29, 2024. The average Travere Therapeutics stock price prediction forecasts a potential upside of 137.53% from the current TVTX share price of $8.42.

What is TVTX's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: TVTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.05%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.